A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure
Clinical trial NCT01877915 · COMPLETED
Trial details
- NCT number
- NCT01877915
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-10
- Primary completion
- 2018-04-19
- Enrollment
- 5081
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.